Stephen Shafran
Impact in
- Hepatology top 10%
- Hepatitis C virus research
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
- HIV/AIDS drug development and treatment
Papers in
-
- Hepatitis C virus research 8
-
- HIV/AIDS drug development and treatment 4
- HIV/AIDS Research and Interventions 1
- Co-authors
- John Conly (6 shared papers)Gary Garber (1 shared paper)Peter Phillips (1 shared paper)Irving E. Salit (1 shared paper)Mark Miller (1 shared paper)Fiona Smaill (1 shared paper)K. Williams (1 shared paper)Joel Singer (1 shared paper)
- Journals
- Journal of Hepatology (5 papers)Clinical Infectious Diseases (1 paper)International Journal of STD & AIDS (1 paper)European Journal of Clinical Microbiology & Infectious Diseases (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Stephen Shafran
14 papers receiving 294 citations
Peers
Comparison fields: 5 of 53
- Hepatology 95
- Infectious Diseases 199
- Applied Microbiology and Biotechnology 19
- Epidemiology 231
- Critical Care and Intensive Care Medicine 17
Countries citing papers authored by Stephen Shafran
This map shows the geographic impact of Stephen Shafran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Shafran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Shafran more than expected).
Fields of papers citing papers by Stephen Shafran
This network shows the impact of papers produced by Stephen Shafran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Shafran. The network helps show where Stephen Shafran may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Shafran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 172 | |
| 2 | 2017 | 50 | |
| 3 | 2015 | 30 | |
| 4 | 2013 | 22 | |
| 5 | 1993 | 18 | |
| 6 | 2019 | 11 | |
| 7 | 2002 | 4 | |
| 8 | 2013 | 2 | |
| 9 | 1995 | 1 | |
| 10 | 1993 | 1 | |
| 11 | 1997 | 1 | |
| 12 | 2007 | 1 | |
| 13 | 2016 | 1 | |
| 14 | QUARTZ II-III: Final Efficacy and Safety Results in Patients with HCV Genotype 2 or 3 Infection Treated With Ombitasvir/Paritaprevir/Ritonavir and Sofosbuvir With or Without Ribavirin | 2016 | 1 |
| 15 | 1995 | 0 |
About Stephen Shafran
Stephen Shafran is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Genetics and Rheumatology, having authored 15 papers that have together received 315 indexed citations. Recurring topics across this work include Hepatitis C virus research (8 papers), HIV/AIDS drug development and treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Hepatitis B Virus Studies (2 papers), Systemic Lupus Erythematosus Research (2 papers), HIV Research and Treatment (1 paper), Cystic Fibrosis Research Advances (1 paper) and HIV/AIDS Research and Interventions (1 paper). The work is most often cited by research in Hepatology (95 citations), Infectious Diseases (199 citations), Applied Microbiology and Biotechnology (19 citations), Epidemiology (231 citations) and Critical Care and Intensive Care Medicine (17 citations). Stephen Shafran has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include John Conly, Gary Garber, Peter Phillips, Irving E. Salit, Mark Miller, Fiona Smaill, K. Williams, Joel Singer, Coleman Rotstein and I. W. Fong. Their work appears in journals such as Journal of Hepatology, Clinical Infectious Diseases, International Journal of STD & AIDS, European Journal of Clinical Microbiology & Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.